Sartorius Stedim Biotech S.A.
$214.36▲ 7.17%(+$14.34)
TickerSpark Score
64/100
▌ Mixed
53
Valuation
65
Profitability
80
Growth
72
Health
50
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SDMHF research report →
52-Week Range42% of range
Low
$178.30
Current
$214.36
High
$264.30
Company Overviewwww.sartorius.com
About the company
Sartorius Stedim Biotech S. A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
- CEO
- René Fáber
- IPO
- 2009
- Employees
- 10,009
- HQ
- Aubagne, FR
Price Chart
-8.35% · this period
Valuation
- Market Cap
- $20.86B
- P/E
- 65.53
- P/S
- 5.87
- P/B
- 4.27
- EV/EBITDA
- 23.29
- Div Yield
- 0.38%
Profitability
- Gross Margin
- 44.71%
- Op Margin
- 18.47%
- Net Margin
- 8.98%
- ROE
- 6.60%
- ROIC
- 5.47%
Growth & Income
- Revenue
- $2.97B · 6.70%
- Net Income
- $265.50M · 51.63%
- EPS
- $2.73 · 50.83%
- Op Income
- $548.79M
- FCF YoY
- -69.42%
Performance & Tape
- 52W High
- $264.30
- 52W Low
- $178.30
- 50D MA
- $196.08
- 200D MA
- $216.16
- Beta
- 1.15
- Avg Volume
- 1.39K
Get TickerSpark's AI analysis on SDMHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · SDMHF
Our SDMHF coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on SDMHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SDMHF report →Internal Compare
Similar companies
Peers in the same neighborhood.